Artificial Intelligence in the COVID-19 Response: Strategies to Improve the Impact of AI on Health Equity (Review Report Volume 2)
PCORI and RAND collaborated on this project, which focused on 2 related but separate topics: (1) the use of artificial intelligence (AI) applications in the COVID-19 response, and (2) strategies to mitigate negative impacts and enhance positive impacts of AI on health equity. The first topic is covered in a companion report, while the second topic is covered in this report.
This report draws from the content of a previously published PCORI-funded journal article on strategies to improve the impact of AI on health equity. This report expands upon that article by including full descriptions of each of the equity-related issues raised by the use of AI in health care as well as the strategies proposed to address those issues that we identified in our review.
Project page: Emerging Technologies and Therapeutics Reports: Artificial Intelligence in the COVID-19 Response
| About the Emerging Technologies and Therapeutics Reports The Emerging Technologies and Therapeutics Reports provide timely summaries of evidence supporting new drugs, devices, and other healthcare technologies that are recently in use or may be available in the near term in the United States. The documents also identify gaps that need to be addressed for the technologies or therapeutics to move forward. |
